Avestar Capital’s GE HealthCare GEHC Stock Holding History

Avestar Capital’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,597	Closed	-$203K	–	516
2024 Q4	$203K	Buy	2,597 +74	+3%	+$6.29K	0.02%	483
2024 Q3	$237K	Buy	+2,523	New	+$212K	0.02%	412

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Avestar Capital's GEHC Position: Q1 2025 in Review

Avestar Capital sold out of GE HealthCare (GEHC) in Q1 2025, closing a stake of 2,597 shares — an estimated $203K sold.

Avestar Capital first reported a position in GEHC in Q3 2024 and held it in 2 quarters. The position peaked at $237K in Q3 2024. 1,371 funds tracked by Wall St. Rank hold GEHC as of Q1 2025.

Avestar Capital reported no remaining GE HealthCare position as of Q1 2025 after selling out during the quarter.
Avestar Capital sold 2,597 GE HealthCare shares in Q1 2025, an estimated $203K.
Avestar Capital first reported a position in GE HealthCare in Q3 2024 and held it in 2 quarters.
Avestar Capital's GE HealthCare position peaked at $237K in Q3 2024.
1,371 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2025.

Based on Avestar Capital's 13F filing for Q1 2025, filed 14 May 2025.